This schedule maintains a consistent dose throughout the 4-week cycle, delivering approximately 1.7 mg GHK-Cu, 0.33 mg TB-500, and 0.33 mg BPC-157 per injection
Some experimental structures explore: 48 week research durations Periodic non-research intervals between protocols Storage & Handling Store refrigerated at 28C Protect from excessive heat and sunlight Use clean laboratory handling practices Avoid repeated contamination of the vial Important Disclaimer For Laboratory and Research Purposes Only Not intended for human consumption or therapeutic use
Clean the rubber septum of your tirzepatide vial with an alcohol prep pad using a circular motion for 30 seconds, then allow it to air dry completely
Injectable long-term use Studies on injectable tirzepatide extend to 72 weeks (about 16 months) with consistent efficacy
3 In other words, rather than eliminating uric acid, a healthy kidney returns up to 90% of it to the bloodstream
Deeper tissue or nerve healing takes longer
